Abstract
Background Although the antiemetic effect of olanzapine on chemotherapy-induced nausea and vomiting has been characterized, the prophylactic role of olanzapine on postoperative nausea and vomiting (PONV) has not been fully elucidated. This clinical trial aims to examine the effectiveness of olanzapine for preventing PONV.
Methods Patients undergoing laparoscopic gynecological surgery at 5 university hospitals in Japan will be randomly assigned to receive either 5 mg of oral olanzapine or placebo 2 hours before the induction of anesthesia. All patients will receive intravenous dexamethasone at the induction of anesthesia. The primary outcome will be the incidence of postoperative nausea and vomiting within 24 hours after surgery. Secondary endpoints will include longitudinal changes in the incidence of postoperative nausea and vomiting and overall patient satisfaction.
Discussion This trial will provide a high quality evidence whether olanzapine prevents PONV in gynecological laparoscopy patients at a high risk for PONV.
Ethics and dissemination The trial was approved by the institutional review board of the each participating study site. Study findings will be disseminated through peer-reviewed publications and in conference presentations.
Trial registration UMIN Clinical Trials Registry (UMIN-CTR) ID: 000022634, Registered on October 1, 2016 https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000026031
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
000022634
Funding Statement
This research is supported by a research grant from the Japanese Society of Anesthesiologists, with additional support provided by a research grant from MSD, Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Each center obtained prior approval from their ethics committees.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available: No. Explanation for why data not available: The informed consent form signed by the patients did not address an individual data sharing statement.
List of abbreviations
- ALP
- Alkaline phosphatase
- ALT
- Alanine aminotransferase
- AST
- Aspartate aminotransferase
- γGTP
- Gamma-glutamyl transpeptidase
- CINV
- Chemotherapyinduced nausea and vomiting
- Dept
- Department
- PONV
- Postoperative nausea and vomiting
- TG
- Triglyceride
- TC
- Total cholesterol
- UNMIN
- University Hospital Medical Information Network
- VAS
- Visual analogue scale
